On the morning of July 11, 2021 China Psoriasis Diagnosis and Treatment Guide Tour and Dandelion Action and GPA offline + online first training event was successfully held in Hefei, Anhui This event is sponsored by the Psoriasis Committee of the Chinese Medical Association Dermatology and Venereology Branch and the Anhui Health Service Association, co-organized by Guangdong Zhonghao Pharmaceutical Co., Ltd., the First Affiliated Hospital of Anhui Medical University and Anhui Medical University Dermatology Research The specific contractor. Professor Zhang Xuejun, Chairman of the Psoriasis Specialty Committee of the Chinese Medical Association Dermatology and Venereology Branch, and Coordinator of the International Psoriasis Surveillance Project (GPA) Asia Pacific Region, Professor Lu Yan, Director of the Dermatology Department of Jiangsu Provincial People's Hospital, The First Affiliated Hospital of Anhui Medical University Professor Wang Zaixing, Director of the Department of Dermatology, Professor Sun Liangdan, Director of the Psoriasis Research Center of the Chinese Association of Dermatology and Venereology, Professor Chen Sitai, Chief Physician of the Department of Dermatology, Taizhou People’s Hospital, Professor Li Xin, Executive Director of the Department of Dermatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine , Associate Professor Zhu Zhengwei, China Regional Secretary of the Psoriasis Specialty Committee of the Chinese Medical Association Dermatology and Venereology Branch and International Psoriasis Surveillance Project (GPA), Mr. Li Fan, Deputy General Manager of Zhonghao Pharmaceutical Marketing of Guanhao Biological Group, and from Anhui and More than 40 people from county and city-level dermatologists from surrounding provinces participated in this meeting, and a total of 100,000 people watched the event live online on the "Medicine My Bank" applet.

Activity site

        This meeting was presided over by Professor Sun Liangdan. Professor Zhang Xuejun first gave an opening speech. This event was the first of a series of 12 events this year. The series of events included a tour guide for psoriasis diagnosis and treatment, dandelion science education and GPA project training. Professor Zhang introduced the International Psoriasis Surveillance Project (GPA), which was developed by the International Skin The Federation of Scientific Societies and the International Psoriasis Association jointly initiated the collection of psoriasis information databases in different regions of the world. Its purpose is to record and use global and regional psoriasis health care data to determine the global burden of psoriasis and provide the world Decision makers, stakeholders, health care workers and patients everywhere provide accurate health data. Psoriasis Diagnosis and Treatment Guide Tour With the help of the "Chinese Psoriasis Diagnosis and Treatment Guide" edited by the Psoriasis Special Committee, more than 30 sessions have been carried out since 2020. The purpose is to help Chinese dermatologists standardize the diagnosis and treatment of psoriasis. Especially to improve the level of diagnosis and treatment of primary dermatologists. Since 2015, Dandelion popular science education activities have been carried out in more than 100 all over the country, and have achieved good social response. It has enabled all walks of life to correctly understand psoriasis and help patients with psoriasis in diet, skin care, medication, prevention of recurrence, etc. Carry out popular science education in many ways. The Psoriasis Committee of the Chinese Medical Association Pediatrics and Venereology Branch has worked on the development of psoriasis diagnosis and treatment guidelines and biologics expert consensus, the compilation of the "Psoriasis Interpretation" popular science book, and the establishment of nearly 300 psoriasis specialists nationwide Outpatient clinics, carrying out dandelion science popularization activities, and undertaking China's psoriasis surveillance project, basically constructing China's psoriasis diagnosis and treatment prevention and control system. Finally, Professor Zhang expressed his gratitude to Guangdong Zhonghao Pharmaceutical Co., Ltd. for its strong support for this event. He hoped that through the organization of this event, dermatologists at all levels can gain something, and finally participate in the China GPA project. Only completing tasks, while collecting samples for scientific research, improving the level and influence of the undergraduate room.

Speech by Professor Zhang Xuejun

Chaired by Professor Sun Liangdan

        Then Mr. Li Fan was invited to give a speech, expressing his sincere gratitude to the conference for giving the first class of new Chinese drug Benvimod this opportunity to learn and exchange. Explains the determination of Guanhao Bio-Zhonghao Pharmaceutical Co., Ltd. to adhere to the "heart of a child", to develop and produce new drugs that are "world-wide", and to continue to care for the "romantic" life of psoriasis patients. This is exactly the three words "Xinbike". Where the mission is. Finally, Mr. Li Fan sent sincere blessings to the successful convening of this event.

Speech by Mr. Li Fan

        This event is the 2021 China Psoriasis Diagnosis and Treatment Guide Tour and Dandelion Action and the first GPA offline + online training event. The launch ceremony was held during the event Take a photo with us, announcing the official start of a series of activities in 2021.

2021 China Psoriasis Diagnosis and Treatment Guidelines Tour, Dandelion Action and GPA Training Activities Officially Launched

        Professor Wang Zaixing first made an overall interpretation of the 2018 "Guidelines for the Diagnosis and Treatment of Psoriasis in China". From the definition of psoriasis, epidemiology, Diagnosis and treatment status, writing background, pathogenesis of psoriasis, clinical manifestations of various types of psoriasis, diagnosis and differential diagnosis, severity classification, comorbidity of psoriasis, purpose and principles of treatment, topical therapy of psoriasis , System therapy, physical therapy, treatment of different types of psoriasis with traditional Chinese medicine, treatment of psoriasis in special parts and special populations, and management and prevention of psoriasis. Essentials of diagnosis and treatment.

Professor Wang Zaixing's interpretation of "Guidelines for Diagnosis and Treatment of Psoriasis in China"

        Professor Lu Yan shared the "Psoriasis Specialty Outpatient Clinic Introduction and Diagnosis and Treatment Experience Sharing", and systematically introduced the Psoriasis Specialty Clinic of the Dermatology Department of Jiangsu Provincial People's Hospital The basic situation of psoriasis, the number of psoriasis outpatient visits, health education, popular science publicity, publication of articles, access to funds, academic exchanges, popular science books, new drug clinical trials and other related achievements; at the same time shared the experience of psoriasis diagnosis and treatment: including according to the financial ability of patients Develop a personalized plan, develop a refined plan according to the needs of the disease, do not give up classic treatment, skin barrier protection, appropriate combined use of physical therapy, help patients identify counterfeit drugs and fake therapies, mixed hormones or cytotoxic drugs, fake doctors, attention and AD, vice Psoriasis, skin lymphoma and other diseases similar to skin rashes are distinguished.

Professor Lu Yan shared "Psoriasis Specialty Outpatient Clinic Introduction and Diagnosis and Treatment Experience Sharing"

        Professor Li Xin shared "The application and prospect of Benvimod in the treatment of inflammatory skin", introducing inflammatory skin diseases such as AD, psoriasis, and vitiligo , Acne and seborrheic dermatitis. Benvimod can repair and maintain skin barrier homeostasis by activating AhR, induce and promote the generation of Treg, enhance the immune tolerance of LC cells, and induce LC to secrete immunosuppressive factors IL-10, maintain the autoimmune homeostasis of LC; the antioxidant AhR agonist Benvimod can reduce the level of ROS and reduce the level of key factors related to inflammatory skin diseases: IL-17, reduce the level of inflammatory skin diseases Key factor level: IL-4. At the same time, it was pointed out that Benvimod, as an agonist (antioxidant) of AhR, has a wide range of application scenarios for the treatment of inflammatory skin. Finally, Professor Li shared the data of the Phase III clinical trial of Benvimod in the treatment of psoriasis. The treatment for 12 weeks was significantly better than calcipotriol; the treatment of patients with atopic dermatitis was effective, and the symptoms of itching were significantly improved after 2 weeks of treatment; Treatment 12 The weekly response rate was significantly better than that of the control group.

Professor Li Xin shared "The application and prospect of Benvimod in the treatment of inflammatory skin"

        Professor Chen Sitai shared "Dandelion Action-Those Things about Psoriasis", from understanding psoriasis, patient psychology, diet and life, work and marriage Popular science education was conducted in several areas such as education, psoriasis prevention and treatment. Professor Chen pointed out that psoriasis is ultimately the result of the combined effects of internal and external factors; patients with psoriasis should maintain a positive and cheerful attitude, three points of treatment, seven points of conditioning, pessimism, anxiety, depression, etc. are harmful to the disease but not beneficial; in terms of diet Supplementary nutrition is required, reasonable collocation, the taboo needs to be different from person to person, not absolute; suitable for work, full of confidence, stable condition in marriage and childbirth, mild patients, those who are interested, can marry and have children; finally, point out psoriasis Diseases are preventable and curable. Today, with the development of science and technology, patients with psoriasis will finally usher in their own spring.

Professor Chen Sitai shared "Dandelion Action-Psoriasis Things"

        Associate Professor Zhu Zhengwei shared "China's GPA Eye-catching Work Advancement", on the work of the Chinese Medical Association Psoriasis Committee, the application for psoriasis specialist outpatient clinics and China GPA The work was introduced, and the conditions for the establishment of specialized outpatient clinics, the application details, the tasks of the GPA project, the target rights and rights sharing, and the role and business functions of the CGPA electronic system were shared in detail. It is hoped that through the implementation of the China GPA project, a set of data on the flow of psoriasis belonging to China can be compiled. It is believed that the establishment of GPA in China will not only help dermatologists to conduct a comprehensive assessment of psoriasis patients and understand their prevalence, but will also be beneficial to clinical science education, help patients improve their lifestyle, reduce recurrence rate, and improve the quality of life.

Associate Professor Zhu Zhengwei shared "China's GPA Eye-catching Work Advancement"

        After the academic activities, the participating experts discussed their experience in the diagnosis and treatment of psoriasis, precautions for drug use, and application of new drugs for expansion of indications.

Discussion in the meeting

        Professor Sun finally summarized the event, and pointed out that through the launch of the GPA series of activities in 2021, it will be able to benefit Chinese dermatologists, especially grassroots doctors. The popularization of science, standardized diagnosis and treatment, and the application of new drugs play an active role in promoting the use of scoria. At the same time, it is hoped that more dermatologists will join the Psoriasis Specialty Clinic and the Chinese Psoriasis Surveillance Project (GPA), Win-win cooperation, and jointly make greater contributions to the prevention and treatment of psoriasis in China.

Professor Sun Liangdan concludes

Meeting photo

Scan and identify the applet to replay and watch the whole content of this event

Photo: Zhu Zhengwei

July 13, 2021